-
2022-501099-24-00
5
2023-12-22
Migraine
-
2022-501100-94-00
5
2023-11-08
Episodic Migraine
-
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
-
2024-516993-31-00
5
2026-05-11
Renal Cell Carcinoma
-
2025-521316-19-00
6
2026-04-20
Urolithiasis
-
2023-505556-21-00
5
2026-03-12
cocaine use disorder
-
2025-521117-88-00
5
2026-03-11
Cardiovascular Disease
-
2024-516356-18-00
5
2026-02-17
Atherosclerotic cardiovascular disease (ASCVD)
-
2025-521692-31-00
5
2025-12-19
Chronic Primary Immune Thrombocytopenia
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2024-514401-54-00
5
2025-11-13
Chronic Primary Immune Thrombocytopenia
-
2025-521260-35-00
6
2025-11-07
acute ischemic stroke and atrial fibrillation (AF)
-
2023-509175-16-00
5
2025-10-14
Sickle cell disease
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2025-521377-14-00
4
2025-10-06
Atrial fibrillation
-
2024-513836-28-00
5
2025-06-23
Chronic Migraine
-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2024-517343-31-00
6
2025-04-11
Ischemic stroke and transient ischemic attack
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2024-512950-13-00
11
2025-01-03
Sepsis
-
2024-513092-40-00
6
2024-12-05
Stroke
-
2024-514055-15-00
6
2024-11-19
Pulmonary sarcoidosis
-
2024-516939-28-00
4
2024-10-28
metastatic castration-resistant prostate cancer